$51.9 Million is the total value of Greylock XII GP LLC's 3 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RDFN | REDFIN CORP | $35,145,000 | -6.3% | 2,087,012 | 0.0% | 67.75% | -11.5% | |
CLDR | CLOUDERA INC | $15,149,000 | +68.4% | 1,709,865 | 0.0% | 29.20% | +59.1% | |
WORK | SLACK TECHNOLOGIES INC | $1,578,000 | -36.7% | 66,517 | 0.0% | 3.04% | -40.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
REDFIN CORP | 8 | Q3 2019 | 76.6% |
CLOUDERA INC | 8 | Q3 2019 | 50.5% |
TWITTER, INC. | 3 | Q2 2016 | 100.0% |
KALA PHARMACEUTICALS, INC. | 3 | Q1 2019 | 2.6% |
SLACK TECHNOLOGIES INC | 2 | Q3 2019 | 5.1% |
PANDORA MEDIA, INC. | 1 | Q2 2013 | 100.0% |
APPTIO, INC. | 1 | Q3 2016 | 100.0% |
ZAFGEN, INC. | 1 | Q4 2015 | 2.0% |
RHYTHM PHARMACEUTICALS, INC. | 1 | Q3 2018 | 1.1% |
No Issuers to Report | 1 | Q3 2013 | 0.0% |
View Greylock XII GP LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2021-05-05 |
13F-HR | 2019-11-13 |
4 | 2019-10-01 |
3 | 2019-09-25 |
13F-HR | 2019-08-14 |
13F-HR | 2019-05-01 |
13F-HR | 2019-05-01 |
13F-HR | 2018-11-01 |
13F-HR | 2018-08-01 |
13F-HR | 2018-05-01 |
View Greylock XII GP LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.